– Report Highlights Accomplishments in 2022 and Outlines Material Topics Through the Concept of Shared Value – NEW YORK–(BUSINESS WIRE)–Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today published its inaugural Corporate Sustainability Report. The report highlights the company’s vision and approach to corporate sustainability, summarizes … [Read more…]

Revenue of $3,652 million GAAP Net Income of $289 million, Adjusted EBITDA of $851 million GAAP Diluted Earnings per Share of $1.53, Adjusted Diluted Earnings per Share of $2.45 R&D Solutions quarterly bookings of $2.6 billion, representing book-to-bill ratio of 1.28x R&D Solutions contracted backlog of $27.9 billion grew 10.1 percent year-over-year and 11.3 percent … [Read more…]

– Company to receive proceeds of $110 million upon closing of the agreement – – Financing to support commercial launch of VOWST™ and fund pipeline development – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it has entered into a new $250 million senior secured debt facility (“Term … [Read more…]

EL DORADO HILLS, Calif.–(BUSINESS WIRE)–#O2Investment–Frontier Dental Lab Group (“Frontier” or “FDL Group”) (www.frontierdentallabgroup.com), an integrated dental lab platform, announced today that it has partnered with and made an investment in Friendship Dental Laboratories, LLC (“Friendship”) (https://friendshipdentallab.com/), a full-service dental laboratory based in Rosedale, MD. Brent West, President of FDL Group, commented, “Friendship is known as … [Read more…]

BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will release financial results for first quarter ended March 31, 2023 after the close of trading on Thursday, May 11. Biodesix’s management will host a conference call and webcast to discuss its … [Read more…]

The Non-Insured Health Benefits (NIHB) program establishes exemplary coverage for Dexcom’s real-time continuous glucose monitoring system – bringing game-changing technology to more First Nations and Inuit peoples for improved diabetes management BURNABY, British Columbia–(BUSINESS WIRE)–Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, applauds the progressive expansion … [Read more…]

Turkish Medicines and Medical Devices Agency assigns priority review status for Drogsan’s Marketing Authorization application and high priority status for Drogsan’s GMP application for Triferic AVNU WIXOM, Mich.–(BUSINESS WIRE)–$RMTI #EndStageKidneyDisease–Rockwell Medical, Inc. (the “Company”) (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific and Middle East NGS Market: Focus on Offering, Platform, Throughput, Technology Type, Application, End User, and Country Analysis – Analysis and Forecast, 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The Asia-Pacific and Middle East NGS market was valued at $1,055.6 million in 2022 and is anticipated to reach $2,370.7 million by … [Read more…]

The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers – Clariscan (gadoteric acid) and Pixxoscan (gadobutrol) Pixxoscan has the same active substance (gadobutrol) and the same qualitative and quantitative composition as the reference product, Gadovist® The availability of Pixxoscan will give … [Read more…]

MILAN–(BUSINESS WIRE)–Deenova, Europe’s leading provider of hospital pharmacy automation unit dose medication solutions, announced today the award of two competitive UniHA tender in France for three of its market-leading solution ACCED, with Drôme Vivarais hospital in Montéléger and St-Marcellin hospital. The ACCED mechatronics solution, which is already in use in over 60 French hospitals, is … [Read more…]